5-Amino-1-isopropyl-1H-pyrazole-4-carbonitrile

Catalog No. :
ACMXYD435
CAS No. :
21254-23-9
Molecular Formula :
C7H10N4
Molecular Weight :
150.18

IUPAC Name:5-amino-1-isopropyl-1H-pyrazole-4-carbonitrile

5-Amino-1-isopropyl-1H-pyrazole-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$86.00Login to see priceIn stockInquiry
250mg95%$142.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Amino-1-isopropyl-1H-pyrazole-4-carbonitrile
IUPAC Name5-amino-1-isopropyl-1H-pyrazole-4-carbonitrile
MDL No.MFCD12405830
Molecular FormulaC7H10N4
Molecular Weight150.18
SMILESN#CC1=C(N)N(C(C)C)N=C1
InChI KeyHWLUYAARRNLXJL-UHFFFAOYSA-N
Synonym1H-Pyrazole-4-carbonitrile,5-amino-1-(1-methylethyl)-(9CI);5-AMINO-1-ISOPROPYL-1H-PYRAZOLE-4-CARBONITRILE;5-AMino-1-isopropyl-pyrazole-4-carbonitrile;5-amino-1-(propan-2-yl)-1H-pyrazole-4-carbonitrile;5-amino-1-propan-2-ylpyrazole-4-carbonitrile;5-amino-1-propan-2-yl-4-pyrazolecarbonitrile;1H-Pyrazole-4-carbonitrile, 5-amino-1-(1-methylethyl)-
CAS No.21254-23-9
PubChem CID17962028

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMXYD435 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMXYD435 route product structure diagram
    ACMXYD43521254-23-9 In Stock
Inquiry

2. ACMXYD435 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMXYD435 route product structure diagram
    ACMXYD43521254-23-9 In Stock
Inquiry

Comments (0)